nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA1—esophageal cancer	0.417	0.569	CbGaD
Acetazolamide—CA2—esophageal cancer	0.316	0.431	CbGaD
Acetazolamide—CA3—pericardium—esophageal cancer	0.0127	0.197	CbGeAlD
Acetazolamide—AQP1—exocrine gland—esophageal cancer	0.00635	0.0982	CbGeAlD
Acetazolamide—CA6—exocrine gland—esophageal cancer	0.00492	0.076	CbGeAlD
Acetazolamide—Methazolamide—CA1—esophageal cancer	0.00371	0.569	CrCbGaD
Acetazolamide—Methazolamide—CA2—esophageal cancer	0.00281	0.431	CrCbGaD
Acetazolamide—AQP1—epithelium—esophageal cancer	0.00276	0.0427	CbGeAlD
Acetazolamide—AQP1—bronchus—esophageal cancer	0.00272	0.0421	CbGeAlD
Acetazolamide—AQP1—smooth muscle tissue—esophageal cancer	0.00266	0.0412	CbGeAlD
Acetazolamide—AQP1—trachea—esophageal cancer	0.00244	0.0378	CbGeAlD
Acetazolamide—AQP1—digestive system—esophageal cancer	0.0021	0.0325	CbGeAlD
Acetazolamide—Hepatic insufficiency—Methotrexate—esophageal cancer	0.00197	0.0779	CcSEcCtD
Acetazolamide—CA7—trachea—esophageal cancer	0.00195	0.0302	CbGeAlD
Acetazolamide—AQP1—lung—esophageal cancer	0.00176	0.0271	CbGeAlD
Acetazolamide—CA2—exocrine gland—esophageal cancer	0.00169	0.0262	CbGeAlD
Acetazolamide—CA7—digestive system—esophageal cancer	0.00168	0.026	CbGeAlD
Acetazolamide—CA9—digestive system—esophageal cancer	0.00148	0.0228	CbGeAlD
Acetazolamide—CA4—neck—esophageal cancer	0.00131	0.0202	CbGeAlD
Acetazolamide—CA3—lung—esophageal cancer	0.00129	0.0199	CbGeAlD
Acetazolamide—CA12—trachea—esophageal cancer	0.00127	0.0196	CbGeAlD
Acetazolamide—AQP1—lymph node—esophageal cancer	0.0012	0.0186	CbGeAlD
Acetazolamide—CA12—digestive system—esophageal cancer	0.00109	0.0169	CbGeAlD
Acetazolamide—CA2—neck—esophageal cancer	0.00108	0.0167	CbGeAlD
Acetazolamide—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.000913	0.0361	CcSEcCtD
Acetazolamide—CA12—lung—esophageal cancer	0.000912	0.0141	CbGeAlD
Acetazolamide—CA3—lymph node—esophageal cancer	0.000881	0.0136	CbGeAlD
Acetazolamide—CA1—digestive system—esophageal cancer	0.000865	0.0134	CbGeAlD
Acetazolamide—CA5B—lung—esophageal cancer	0.000818	0.0126	CbGeAlD
Acetazolamide—CA4—trachea—esophageal cancer	0.000786	0.0121	CbGeAlD
Acetazolamide—CA2—epithelium—esophageal cancer	0.000737	0.0114	CbGeAlD
Acetazolamide—CA2—bronchus—esophageal cancer	0.000726	0.0112	CbGeAlD
Acetazolamide—CA1—lung—esophageal cancer	0.000723	0.0112	CbGeAlD
Acetazolamide—CA2—smooth muscle tissue—esophageal cancer	0.00071	0.011	CbGeAlD
Acetazolamide—CA4—digestive system—esophageal cancer	0.000676	0.0104	CbGeAlD
Acetazolamide—CA2—trachea—esophageal cancer	0.000652	0.0101	CbGeAlD
Acetazolamide—Appetite absent—Methotrexate—esophageal cancer	0.000612	0.0242	CcSEcCtD
Acetazolamide—CA4—lung—esophageal cancer	0.000565	0.00873	CbGeAlD
Acetazolamide—CA2—digestive system—esophageal cancer	0.000561	0.00866	CbGeAlD
Acetazolamide—CA5B—lymph node—esophageal cancer	0.00056	0.00865	CbGeAlD
Acetazolamide—Body temperature increased—Carboplatin—esophageal cancer	0.000534	0.0211	CcSEcCtD
Acetazolamide—Tingling sensation—Capecitabine—esophageal cancer	0.000509	0.0201	CcSEcCtD
Acetazolamide—Injection site pain—Capecitabine—esophageal cancer	0.000501	0.0198	CcSEcCtD
Acetazolamide—CA1—lymph node—esophageal cancer	0.000494	0.00764	CbGeAlD
Acetazolamide—CA2—lung—esophageal cancer	0.000468	0.00724	CbGeAlD
Acetazolamide—Polyuria—Cisplatin—esophageal cancer	0.000459	0.0182	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000416	0.0165	CcSEcCtD
Acetazolamide—Hyponatraemia—Cisplatin—esophageal cancer	0.000405	0.016	CcSEcCtD
Acetazolamide—Melaena—Capecitabine—esophageal cancer	0.0004	0.0158	CcSEcCtD
Acetazolamide—CA4—lymph node—esophageal cancer	0.000386	0.00597	CbGeAlD
Acetazolamide—Irritability—Cisplatin—esophageal cancer	0.000385	0.0152	CcSEcCtD
Acetazolamide—Urine output increased—Capecitabine—esophageal cancer	0.00037	0.0146	CcSEcCtD
Acetazolamide—Hypokalaemia—Cisplatin—esophageal cancer	0.000367	0.0145	CcSEcCtD
Acetazolamide—CYP3A4—digestive system—esophageal cancer	0.000362	0.00559	CbGeAlD
Acetazolamide—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00034	0.0134	CcSEcCtD
Acetazolamide—Photosensitivity—Capecitabine—esophageal cancer	0.000338	0.0134	CcSEcCtD
Acetazolamide—Polyuria—Capecitabine—esophageal cancer	0.000338	0.0134	CcSEcCtD
Acetazolamide—Hepatic failure—Capecitabine—esophageal cancer	0.000331	0.0131	CcSEcCtD
Acetazolamide—CA2—lymph node—esophageal cancer	0.00032	0.00495	CbGeAlD
Acetazolamide—Thirst—Capecitabine—esophageal cancer	0.000312	0.0123	CcSEcCtD
Acetazolamide—Hyponatraemia—Capecitabine—esophageal cancer	0.000298	0.0118	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—esophageal cancer	0.000298	0.0118	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000294	0.0116	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—esophageal cancer	0.000286	0.0113	CcSEcCtD
Acetazolamide—Irritability—Capecitabine—esophageal cancer	0.000284	0.0112	CcSEcCtD
Acetazolamide—Ataxia—Capecitabine—esophageal cancer	0.000279	0.011	CcSEcCtD
Acetazolamide—Urine output increased—Methotrexate—esophageal cancer	0.000275	0.0109	CcSEcCtD
Acetazolamide—Hypokalaemia—Capecitabine—esophageal cancer	0.00027	0.0107	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000268	0.0106	CcSEcCtD
Acetazolamide—Tinnitus—Cisplatin—esophageal cancer	0.00026	0.0103	CcSEcCtD
Acetazolamide—Flushing—Cisplatin—esophageal cancer	0.000259	0.0102	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—esophageal cancer	0.000252	0.00996	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—esophageal cancer	0.000252	0.00996	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—esophageal cancer	0.000246	0.00973	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000234	0.00927	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000229	0.00904	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000227	0.00898	CcSEcCtD
Acetazolamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000225	0.00891	CcSEcCtD
Acetazolamide—Malaise—Cisplatin—esophageal cancer	0.000219	0.00866	CcSEcCtD
Acetazolamide—Haematuria—Capecitabine—esophageal cancer	0.000218	0.00863	CcSEcCtD
Acetazolamide—Leukopenia—Cisplatin—esophageal cancer	0.000217	0.00859	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000217	0.00856	CcSEcCtD
Acetazolamide—Agranulocytosis—Capecitabine—esophageal cancer	0.000214	0.00845	CcSEcCtD
Acetazolamide—Irritability—Methotrexate—esophageal cancer	0.000211	0.00835	CcSEcCtD
Acetazolamide—Convulsion—Cisplatin—esophageal cancer	0.00021	0.00832	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—esophageal cancer	0.000208	0.00822	CcSEcCtD
Acetazolamide—Hypoaesthesia—Capecitabine—esophageal cancer	0.000205	0.00809	CcSEcCtD
Acetazolamide—Discomfort—Cisplatin—esophageal cancer	0.000204	0.00807	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000199	0.00788	CcSEcCtD
Acetazolamide—Anaphylactic shock—Cisplatin—esophageal cancer	0.000198	0.00783	CcSEcCtD
Acetazolamide—Erythema multiforme—Capecitabine—esophageal cancer	0.000194	0.00768	CcSEcCtD
Acetazolamide—Thrombocytopenia—Cisplatin—esophageal cancer	0.000194	0.00767	CcSEcCtD
Acetazolamide—Tinnitus—Capecitabine—esophageal cancer	0.000192	0.00758	CcSEcCtD
Acetazolamide—Flushing—Capecitabine—esophageal cancer	0.000191	0.00754	CcSEcCtD
Acetazolamide—Paraesthesia—Cisplatin—esophageal cancer	0.000178	0.00703	CcSEcCtD
Acetazolamide—Dysgeusia—Capecitabine—esophageal cancer	0.000175	0.00693	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000174	0.0069	CcSEcCtD
Acetazolamide—Decreased appetite—Cisplatin—esophageal cancer	0.000172	0.00681	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000171	0.00676	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—esophageal cancer	0.00017	0.00674	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000169	0.00668	CcSEcCtD
Acetazolamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000166	0.00656	CcSEcCtD
Acetazolamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000163	0.00646	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—esophageal cancer	0.000163	0.00643	CcSEcCtD
Acetazolamide—Malaise—Capecitabine—esophageal cancer	0.000161	0.00638	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000161	0.00637	CcSEcCtD
Acetazolamide—Leukopenia—Capecitabine—esophageal cancer	0.00016	0.00633	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—esophageal cancer	0.000159	0.00629	CcSEcCtD
Acetazolamide—Body temperature increased—Cisplatin—esophageal cancer	0.000157	0.00619	CcSEcCtD
Acetazolamide—Discomfort—Capecitabine—esophageal cancer	0.000151	0.00595	CcSEcCtD
Acetazolamide—Confusional state—Capecitabine—esophageal cancer	0.000147	0.00582	CcSEcCtD
Acetazolamide—Erythema multiforme—Methotrexate—esophageal cancer	0.000145	0.00572	CcSEcCtD
Acetazolamide—Shock—Capecitabine—esophageal cancer	0.000144	0.00568	CcSEcCtD
Acetazolamide—Thrombocytopenia—Capecitabine—esophageal cancer	0.000143	0.00565	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—esophageal cancer	0.000143	0.00564	CcSEcCtD
Acetazolamide—Asthenia—Cisplatin—esophageal cancer	0.000142	0.00562	CcSEcCtD
Acetazolamide—Diarrhoea—Cisplatin—esophageal cancer	0.000136	0.00536	CcSEcCtD
Acetazolamide—Paraesthesia—Capecitabine—esophageal cancer	0.000131	0.00518	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—esophageal cancer	0.00013	0.00516	CcSEcCtD
Acetazolamide—Dyspepsia—Capecitabine—esophageal cancer	0.000129	0.00508	CcSEcCtD
Acetazolamide—Decreased appetite—Capecitabine—esophageal cancer	0.000127	0.00502	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000126	0.00499	CcSEcCtD
Acetazolamide—Vomiting—Cisplatin—esophageal cancer	0.000126	0.00498	CcSEcCtD
Acetazolamide—Fatigue—Capecitabine—esophageal cancer	0.000126	0.00498	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.000124	0.00489	CcSEcCtD
Acetazolamide—Feeling abnormal—Capecitabine—esophageal cancer	0.00012	0.00476	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—esophageal cancer	0.00012	0.00475	CcSEcCtD
Acetazolamide—Leukopenia—Methotrexate—esophageal cancer	0.000119	0.00471	CcSEcCtD
Acetazolamide—Nausea—Cisplatin—esophageal cancer	0.000118	0.00465	CcSEcCtD
Acetazolamide—Urticaria—Capecitabine—esophageal cancer	0.000116	0.00459	CcSEcCtD
Acetazolamide—Body temperature increased—Capecitabine—esophageal cancer	0.000115	0.00456	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—esophageal cancer	0.000115	0.00456	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—esophageal cancer	0.000112	0.00443	CcSEcCtD
Acetazolamide—Confusional state—Methotrexate—esophageal cancer	0.00011	0.00433	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—esophageal cancer	0.000109	0.0043	CcSEcCtD
Acetazolamide—Thrombocytopenia—Methotrexate—esophageal cancer	0.000106	0.00421	CcSEcCtD
Acetazolamide—Asthenia—Capecitabine—esophageal cancer	0.000105	0.00414	CcSEcCtD
Acetazolamide—Diarrhoea—Capecitabine—esophageal cancer	9.99e-05	0.00395	CcSEcCtD
Acetazolamide—Paraesthesia—Methotrexate—esophageal cancer	9.76e-05	0.00386	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—esophageal cancer	9.66e-05	0.00382	CcSEcCtD
Acetazolamide—Dizziness—Capecitabine—esophageal cancer	9.66e-05	0.00382	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—esophageal cancer	9.57e-05	0.00378	CcSEcCtD
Acetazolamide—Decreased appetite—Methotrexate—esophageal cancer	9.45e-05	0.00374	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.39e-05	0.00371	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—esophageal cancer	9.37e-05	0.00371	CcSEcCtD
Acetazolamide—Vomiting—Capecitabine—esophageal cancer	9.29e-05	0.00367	CcSEcCtD
Acetazolamide—Headache—Capecitabine—esophageal cancer	9.15e-05	0.00362	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—esophageal cancer	8.96e-05	0.00354	CcSEcCtD
Acetazolamide—Nausea—Capecitabine—esophageal cancer	8.67e-05	0.00343	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—esophageal cancer	8.64e-05	0.00341	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—esophageal cancer	8.59e-05	0.0034	CcSEcCtD
Acetazolamide—Asthenia—Methotrexate—esophageal cancer	7.8e-05	0.00308	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—esophageal cancer	7.44e-05	0.00294	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—esophageal cancer	7.19e-05	0.00284	CcSEcCtD
Acetazolamide—Vomiting—Methotrexate—esophageal cancer	6.91e-05	0.00273	CcSEcCtD
Acetazolamide—Headache—Methotrexate—esophageal cancer	6.81e-05	0.00269	CcSEcCtD
Acetazolamide—Nausea—Methotrexate—esophageal cancer	6.46e-05	0.00255	CcSEcCtD
Acetazolamide—CA1—Metabolism—ADH1B—esophageal cancer	4.32e-05	0.000254	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TYMP—esophageal cancer	4.31e-05	0.000254	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	4.31e-05	0.000253	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ENO1—esophageal cancer	4.28e-05	0.000252	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS1—esophageal cancer	4.28e-05	0.000252	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ENO1—esophageal cancer	4.28e-05	0.000252	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS1—esophageal cancer	4.28e-05	0.000252	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	4.27e-05	0.000251	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTT1—esophageal cancer	4.27e-05	0.000251	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTT1—esophageal cancer	4.27e-05	0.000251	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALOX15—esophageal cancer	4.26e-05	0.000251	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PSME2—esophageal cancer	4.22e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PSME1—esophageal cancer	4.22e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PSME1—esophageal cancer	4.22e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PSME2—esophageal cancer	4.22e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP2A6—esophageal cancer	4.22e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP2A6—esophageal cancer	4.22e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP26A1—esophageal cancer	4.19e-05	0.000247	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ALDH2—esophageal cancer	4.16e-05	0.000245	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMP—esophageal cancer	4.13e-05	0.000243	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALOX15—esophageal cancer	4.09e-05	0.00024	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTO1—esophageal cancer	4.07e-05	0.000239	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TPI1—esophageal cancer	4.07e-05	0.000239	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2A—esophageal cancer	4.06e-05	0.000239	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.04e-05	0.000237	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP26A1—esophageal cancer	4.02e-05	0.000237	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ENO1—esophageal cancer	4e-05	0.000235	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ENO1—esophageal cancer	4e-05	0.000235	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS1—esophageal cancer	4e-05	0.000235	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS1—esophageal cancer	4e-05	0.000235	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTT1—esophageal cancer	3.95e-05	0.000233	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PSME2—esophageal cancer	3.94e-05	0.000232	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PSME1—esophageal cancer	3.94e-05	0.000232	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PSME1—esophageal cancer	3.94e-05	0.000232	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PSME2—esophageal cancer	3.94e-05	0.000232	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALOX15—esophageal cancer	3.92e-05	0.000231	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP2A6—esophageal cancer	3.91e-05	0.00023	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALDOB—esophageal cancer	3.9e-05	0.000229	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TPI1—esophageal cancer	3.9e-05	0.000229	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTO1—esophageal cancer	3.9e-05	0.000229	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ADH1B—esophageal cancer	3.8e-05	0.000224	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	3.76e-05	0.000221	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GAPDH—esophageal cancer	3.75e-05	0.000221	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	3.74e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1B1—esophageal cancer	3.74e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTO1—esophageal cancer	3.74e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALDOB—esophageal cancer	3.74e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TPI1—esophageal cancer	3.74e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CRABP1—esophageal cancer	3.72e-05	0.000219	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ENO1—esophageal cancer	3.7e-05	0.000218	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS1—esophageal cancer	3.7e-05	0.000218	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CREBBP—esophageal cancer	3.68e-05	0.000217	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.66e-05	0.000215	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PSME1—esophageal cancer	3.65e-05	0.000215	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PSME2—esophageal cancer	3.65e-05	0.000215	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1B1—esophageal cancer	3.64e-05	0.000214	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1B1—esophageal cancer	3.64e-05	0.000214	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMP—esophageal cancer	3.63e-05	0.000214	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GAPDH—esophageal cancer	3.6e-05	0.000212	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALDOB—esophageal cancer	3.58e-05	0.000211	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CRABP1—esophageal cancer	3.57e-05	0.00021	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GNG7—esophageal cancer	3.54e-05	0.000208	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	3.54e-05	0.000208	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP26A1—esophageal cancer	3.53e-05	0.000208	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP19A1—esophageal cancer	3.51e-05	0.000207	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	3.48e-05	0.000205	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GAPDH—esophageal cancer	3.45e-05	0.000203	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALOX15—esophageal cancer	3.44e-05	0.000203	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	3.43e-05	0.000202	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP19A1—esophageal cancer	3.42e-05	0.000202	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP19A1—esophageal cancer	3.42e-05	0.000202	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CRABP1—esophageal cancer	3.42e-05	0.000201	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1B1—esophageal cancer	3.4e-05	0.0002	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1B1—esophageal cancer	3.4e-05	0.0002	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GNG7—esophageal cancer	3.39e-05	0.0002	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	3.32e-05	0.000195	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ALDH2—esophageal cancer	3.31e-05	0.000195	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—NOS3—esophageal cancer	3.3e-05	0.000194	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTO1—esophageal cancer	3.29e-05	0.000193	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TPI1—esophageal cancer	3.29e-05	0.000193	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GNG7—esophageal cancer	3.25e-05	0.000191	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	3.23e-05	0.00019	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—HMOX1—esophageal cancer	3.21e-05	0.000189	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP19A1—esophageal cancer	3.2e-05	0.000188	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP19A1—esophageal cancer	3.2e-05	0.000188	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CREBBP—esophageal cancer	3.19e-05	0.000188	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	3.19e-05	0.000188	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ALDH2—esophageal cancer	3.18e-05	0.000187	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—EP300—esophageal cancer	3.16e-05	0.000186	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTT1—esophageal cancer	3.15e-05	0.000186	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1B1—esophageal cancer	3.15e-05	0.000185	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALDOB—esophageal cancer	3.15e-05	0.000185	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HMOX1—esophageal cancer	3.12e-05	0.000184	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HMOX1—esophageal cancer	3.12e-05	0.000184	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP2A6—esophageal cancer	3.12e-05	0.000183	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ABCB1—esophageal cancer	3.08e-05	0.000181	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ALDH2—esophageal cancer	3.05e-05	0.000179	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GAPDH—esophageal cancer	3.03e-05	0.000178	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTT1—esophageal cancer	3.02e-05	0.000178	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—esophageal cancer	3.01e-05	0.000177	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CRABP1—esophageal cancer	3.01e-05	0.000177	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ABCB1—esophageal cancer	3e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ABCB1—esophageal cancer	3e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP2A6—esophageal cancer	2.99e-05	0.000176	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP19A1—esophageal cancer	2.96e-05	0.000174	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ENO1—esophageal cancer	2.95e-05	0.000174	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS1—esophageal cancer	2.95e-05	0.000174	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HMOX1—esophageal cancer	2.92e-05	0.000172	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HMOX1—esophageal cancer	2.92e-05	0.000172	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PSME2—esophageal cancer	2.91e-05	0.000171	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PSME1—esophageal cancer	2.91e-05	0.000171	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTT1—esophageal cancer	2.9e-05	0.000171	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP2A6—esophageal cancer	2.86e-05	0.000169	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GNG7—esophageal cancer	2.86e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—NOS3—esophageal cancer	2.86e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ENO1—esophageal cancer	2.83e-05	0.000167	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS1—esophageal cancer	2.83e-05	0.000167	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ABCB1—esophageal cancer	2.8e-05	0.000165	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ABCB1—esophageal cancer	2.8e-05	0.000165	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PSME2—esophageal cancer	2.79e-05	0.000164	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PSME1—esophageal cancer	2.79e-05	0.000164	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ENO1—esophageal cancer	2.72e-05	0.00016	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS1—esophageal cancer	2.72e-05	0.00016	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HMOX1—esophageal cancer	2.7e-05	0.000159	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALDH2—esophageal cancer	2.68e-05	0.000158	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PSME1—esophageal cancer	2.68e-05	0.000157	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PSME2—esophageal cancer	2.68e-05	0.000157	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	2.64e-05	0.000155	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—esophageal cancer	2.61e-05	0.000154	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ABCB1—esophageal cancer	2.59e-05	0.000153	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTT1—esophageal cancer	2.55e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP2A6—esophageal cancer	2.52e-05	0.000148	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1B1—esophageal cancer	2.51e-05	0.000148	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	2.51e-05	0.000148	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—EP300—esophageal cancer	2.51e-05	0.000148	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	2.48e-05	0.000146	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1B1—esophageal cancer	2.41e-05	0.000142	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS1—esophageal cancer	2.39e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ENO1—esophageal cancer	2.39e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP19A1—esophageal cancer	2.36e-05	0.000139	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PSME2—esophageal cancer	2.35e-05	0.000138	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PSME1—esophageal cancer	2.35e-05	0.000138	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	2.35e-05	0.000138	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1B1—esophageal cancer	2.31e-05	0.000136	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP19A1—esophageal cancer	2.26e-05	0.000133	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—esophageal cancer	2.26e-05	0.000133	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.23e-05	0.000131	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—EP300—esophageal cancer	2.17e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP19A1—esophageal cancer	2.17e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HMOX1—esophageal cancer	2.16e-05	0.000127	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.14e-05	0.000126	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCB1—esophageal cancer	2.07e-05	0.000122	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HMOX1—esophageal cancer	2.07e-05	0.000122	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CREBBP—esophageal cancer	2.06e-05	0.000121	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1B1—esophageal cancer	2.03e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CREBBP—esophageal cancer	2e-05	0.000118	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CREBBP—esophageal cancer	2e-05	0.000118	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2e-05	0.000118	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCB1—esophageal cancer	1.98e-05	0.000117	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HMOX1—esophageal cancer	1.98e-05	0.000117	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	1.97e-05	0.000116	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP19A1—esophageal cancer	1.91e-05	0.000112	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCB1—esophageal cancer	1.9e-05	0.000112	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	1.88e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CREBBP—esophageal cancer	1.87e-05	0.00011	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CREBBP—esophageal cancer	1.87e-05	0.00011	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—esophageal cancer	1.85e-05	0.000109	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	1.85e-05	0.000109	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NOS3—esophageal cancer	1.84e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NOS3—esophageal cancer	1.79e-05	0.000106	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NOS3—esophageal cancer	1.79e-05	0.000106	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HMOX1—esophageal cancer	1.74e-05	0.000102	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CREBBP—esophageal cancer	1.73e-05	0.000102	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—esophageal cancer	1.68e-05	9.91e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NOS3—esophageal cancer	1.68e-05	9.86e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NOS3—esophageal cancer	1.68e-05	9.86e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCB1—esophageal cancer	1.67e-05	9.84e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—esophageal cancer	1.64e-05	9.66e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—esophageal cancer	1.64e-05	9.66e-05	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—esophageal cancer	1.61e-05	9.46e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NOS3—esophageal cancer	1.55e-05	9.13e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—esophageal cancer	1.53e-05	9.02e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—esophageal cancer	1.53e-05	9.02e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.43e-05	8.42e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—esophageal cancer	1.42e-05	8.35e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—EP300—esophageal cancer	1.4e-05	8.24e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CREBBP—esophageal cancer	1.38e-05	8.14e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—EP300—esophageal cancer	1.37e-05	8.03e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—EP300—esophageal cancer	1.37e-05	8.03e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CREBBP—esophageal cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—EP300—esophageal cancer	1.27e-05	7.5e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—EP300—esophageal cancer	1.27e-05	7.5e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CREBBP—esophageal cancer	1.27e-05	7.48e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NOS3—esophageal cancer	1.24e-05	7.28e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NOS3—esophageal cancer	1.19e-05	6.98e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—EP300—esophageal cancer	1.18e-05	6.95e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NOS3—esophageal cancer	1.14e-05	6.7e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—esophageal cancer	1.13e-05	6.66e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CREBBP—esophageal cancer	1.12e-05	6.57e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—esophageal cancer	1.09e-05	6.39e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—esophageal cancer	1.04e-05	6.12e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—esophageal cancer	1.04e-05	6.1e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—esophageal cancer	1.01e-05	5.94e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—esophageal cancer	1.01e-05	5.94e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.01e-05	5.94e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.01e-05	5.94e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NOS3—esophageal cancer	1e-05	5.89e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—esophageal cancer	9.43e-06	5.55e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—esophageal cancer	9.43e-06	5.55e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—EP300—esophageal cancer	9.42e-06	5.54e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—esophageal cancer	9.15e-06	5.38e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—EP300—esophageal cancer	9.03e-06	5.31e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—esophageal cancer	8.73e-06	5.14e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—EP300—esophageal cancer	8.66e-06	5.09e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.58e-06	5.05e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA1—esophageal cancer	8.58e-06	5.05e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA2—esophageal cancer	7.85e-06	4.62e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—EP300—esophageal cancer	7.61e-06	4.48e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.3e-06	4.29e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADH7—esophageal cancer	7.3e-06	4.29e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—esophageal cancer	6.97e-06	4.1e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—esophageal cancer	6.68e-06	3.93e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—esophageal cancer	6.4e-06	3.77e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.4e-06	3.77e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMP—esophageal cancer	6.12e-06	3.6e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.95e-06	3.5e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.8e-06	3.41e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—esophageal cancer	5.63e-06	3.31e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.53e-06	3.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TPI1—esophageal cancer	5.53e-06	3.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.3e-06	3.12e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.1e-06	3e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.06e-06	2.98e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GNG7—esophageal cancer	4.81e-06	2.83e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.51e-06	2.65e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.29e-06	2.52e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.24e-06	2.49e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ENO1—esophageal cancer	4.02e-06	2.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.02e-06	2.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSME2—esophageal cancer	3.96e-06	2.33e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSME1—esophageal cancer	3.96e-06	2.33e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.42e-06	2.01e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.21e-06	1.89e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.93e-06	1.73e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.81e-06	1.66e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.88e-06	1.11e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NOS3—esophageal cancer	1.68e-06	9.91e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.54e-06	9.06e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EP300—esophageal cancer	1.28e-06	7.54e-06	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.48e-07	5.58e-06	CbGpPWpGaD
